1.36 USD
▲+0.04+3.82%
盘后 1.33 +1.53%
2026-08-03
市值
$144.62M
市盈率
—
EPS
-0.28
股息率
—
52 周区间
0.88 – 1.71
成交量
1.54M
Beta
0.51
目标价
7.34
52W 低 0.8852W 高 1.71
价格走势
公司简介
Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product candidate is CardiolRx, which is in Phase III multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis. The company is also developing CRD-38, a novel subcutaneously administered drug formulation of cannabidiol fo...